{
  "report_rows": [
    {
      "kpi": "Q2'26 Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.065B vs. cons $1.05B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2'26 Non-GAAP EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.68 vs. cons $2.64",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2'26 Clear Aligner Volume (cases)",
      "prediction": "BEAT",
      "answer": "pred ~708K vs. cons 697K",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3'26 Revenue Guidance",
      "prediction": "BETTER",
      "answer": "guide ~$1.075B vs. cons $1.06B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3'26 Non-GAAP EPS Guidance",
      "prediction": "BETTER",
      "answer": "guide ~$2.78 vs. cons $2.72 (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Non-GAAP Operating Margin Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~23.7% vs. cons 23.6% (FY2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "North America Clear Aligner Volume Trend (y/y)",
      "prediction": "BETTER",
      "answer": "guide ~-1% vs. cons -3% (Q3 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 4.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.0,
  "day5_path": "STABILIZE",
  "day5_rationale": "A clean top/bottom-line beat with reaffirmed FY26 revenue/margin guidance removes the tail-risk of an implicit out-period cut, supporting the initial pop; but the EU antitrust probe, CLRO/Chairman transitions, and still-tepid (even if 'less bad') North America retail trends cap incremental upside, so analysts likely nudge estimates up modestly rather than sharply re-rate \u2014 price consolidates near the day-1 level over the following days rather than extending or reversing sharply.",
  "day5_confidence": "LOW"
}